Biotech Values

[biomaven0]

I hadn't realized that. But they are pretty much obliged to dose according to the label in a trial even if that isn't the de facto standard.

Here is the INCY/LLY abstract:

https://b-com.mci-group.com/Abstract/Statistics/AbstractStatisticsViewPage.aspx?AbstractID=115194

Looks good to me. Same ballpark as Pfizer's drug tofa on ACR20/50/70. Substantially better performance on DAS28<2.6 (a standard measure of remission) with 37% and 22% for the 4mg and 8mg doses compared with around 10% for the Pfizer drug. It's also once a day rather than tofa's BID.

Peter